Abstract

Luminescence imaging in the second near-infrared (NIR-II) window, particularly within the NIR-IIb (1500–1700 nm) sub-window, has been utilized for both fundamental research and clinical applications due to its exceptional spatiotemporal resolution. Nevertheless, efficient contrast agents designed for NIR-IIb imaging are still scarce. Herein, a multilayered rare-earth nanocrystal (NaYF4:Yb,Er,Ce@NaYF4:Yb,Nd@NaYF4) with strong NIR-IIb luminescence was designed and synthesized. The doping of Ce3+ ions in the core effectively suppresses the upconversion and boosts the downconversion luminescence by populating the Er 4I13/2 level. Additionally, by separating the sensitizer (Nd3+) and the activator (Er3+) in different layers, we are able to maximize the light absorption around 800 nm and reduce the cross relaxations between rare-earth elements, which leads to a strong downconversion emission around 1530 nm under 808 nm excitation. After passivation with NaYF4 shell and phase transfer with highly PEGylated mesoporous silica layer, the nanocomposites with excellent colloidal stability and bright NIR-IIb emission were obtained. With long blood circulation time in vivo, the fabricated nanocomposites enable high resolution and contrast luminescence imaging of the blood vessels and tumors in living mice. Moreover, the rare-earth nanocrystals with superior optical properties also hold great promise for various applications in optical sensing and biomedical imaging.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call